Evidence map›Paper›PMID 28041977›Full record

ArticleCancer letters2017

Induction of the MCP chemokine cluster cascade in the periphery by cancer cell-derived Ccl3.

Elena Farmaki, Vimala Kaza, Athanasios G Papavassiliou, Ioulia Chatzistamou, Hippokratis Kiaris

Abstract read
In one paragraph

Article in Cancer letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The elusive Luminal B breast cancer and the mysterious chemokines.Journal of cancer research and clinical oncology · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Neddylation Regulates Macrophages and Implications for Cancer Therapy.Frontiers in cell and developmental biology · 2021
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Elena FarmakiDepartment of Drug Discovery and Biomedical Sciences, University of South Carolina, SC, USA.
Vimala KazaDepartment of Drug Discovery and Biomedical Sciences, University of South Carolina, SC, USA.
Athanasios G PapavassiliouDepartment of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Ioulia ChatzistamouDepartment of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, SC, USA.
Hippokratis KiarisDepartment of Drug Discovery and Biomedical Sciences, University of South Carolina, SC, USA; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece; Peromyscus Genetic Stock Center, University of South Carolina, SC, USA. Electronic address: kiarish@sccp.sc.edu.
University of South Carolina · USNational and Kapodistrian University of Athens · GR

Funding

TISSUE BIOREPOSITORY COREP30GM103336 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BERGER, FRANKLIN G. · 2013 to 2017
$5.4M
NIGMS NIH HHS P30 GM103336
6 · The paper itself

Abstract

The induction of localized pro-inflammatory niches in the periphery is instrumental in metastasis. In order to better understand how tumors engage distal sites and activate a pro-inflammatory response we utilized syngeneic breast cancers as a model and showed that soluble factors from the neoplastic epithelium activate the expression of the monocyte chemoattractive protein (MCP) chemokines of the mouse 11C cluster that include Ccl1, Ccl2, Ccl7, Ccl8, Ccl11 and Ccl12. Tissues such as the lungs and the brain, that are more prone to colonization by breast cancer cells, were more sensitive to MCP cluster chemokine induction than others such as the liver. Subsequent analyses involving chemokine arrays in breast cancer cells and media followed by functional validation assays in in vitro and in vivo identified the cytokine Ccl3 as the principle mediator of the communication between the neoplastic epithelium and the peripheral tissues in terms of MCP cluster chemokine induction. Our results show that MCP chemokines are activated in peripheral tissues of breast cancer-bearing mice, by a mechanism that involves breast cancer cell-derived Ccl3. Interference with the expression of cancer cell-derived Ccl3 may find application in the management of breast cancer metastases.

Indexed as

AnimalsChemokine CCL3FemaleMammary Neoplasms, ExperimentalMiceMice, Inbred C57BLMonocyte Chemoattractant ProteinsNeoplasm MetastasisNIH 3T3 CellsChemokine CCL3Monocyte Chemoattractant ProteinsBreast cancerCCL3ChemokineInflammationMetastasisPeriphery

Identifiers

PMID28041977
PMCPMC5313349
OpenAlexW2564365065

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.